- Home
- ERAS vs WSR Comparison
ERAS vs WSR Comparison
Compare ERAS & WSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- WSR
- Stock Information
- Founded
- ERAS 2018
- WSR 1998
- Country
- ERAS United States
- WSR United States
- Employees
- ERAS N/A
- WSR N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- WSR Real Estate Investment Trusts
- Sector
- ERAS Health Care
- WSR Real Estate
- Exchange
- ERAS Nasdaq
- WSR Nasdaq
- Market Cap
- ERAS 719.0M
- WSR 739.7M
- IPO Year
- ERAS 2021
- WSR 2010
- Fundamental
- Price
- ERAS $2.67
- WSR $14.33
- Analyst Decision
- ERAS Strong Buy
- WSR Strong Buy
- Analyst Count
- ERAS 5
- WSR 3
- Target Price
- ERAS $6.10
- WSR $15.00
- AVG Volume (30 Days)
- ERAS 1.7M
- WSR 245.9K
- Earning Date
- ERAS 11-12-2024
- WSR 10-30-2024
- Dividend Yield
- ERAS N/A
- WSR 3.45%
- EPS Growth
- ERAS N/A
- WSR N/A
- EPS
- ERAS N/A
- WSR 0.41
- Revenue
- ERAS N/A
- WSR $149,446,000.00
- Revenue This Year
- ERAS N/A
- WSR N/A
- Revenue Next Year
- ERAS N/A
- WSR $4.35
- P/E Ratio
- ERAS N/A
- WSR $34.91
- Revenue Growth
- ERAS N/A
- WSR 4.67
- 52 Week Low
- ERAS $1.51
- WSR $10.77
- 52 Week High
- ERAS $3.45
- WSR $14.80
- Technical
- Relative Strength Index (RSI)
- ERAS 43.56
- WSR 54.38
- Support Level
- ERAS $2.59
- WSR $13.55
- Resistance Level
- ERAS $3.19
- WSR $14.80
- Average True Range (ATR)
- ERAS 0.20
- WSR 0.31
- MACD
- ERAS -0.02
- WSR -0.00
- Stochastic Oscillator
- ERAS 20.13
- WSR 62.00
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. Its property portfolio includes retail and office/flex properties. The company's properties are located in business-friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The organization derives revenue in the form of rental revenues.